Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Daphne Zohar is Chief Executive Officer at Seaport Therapeutics. OQRO lists 1 transaction filed with the SEC under this name, the latest on Nov 13, 2026, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
1
Companies involved
1
Nov 10, 2026100Kdisclosed Nov 13
DetailsOfficial recordOn the latest SEC Form 4, dated Nov 10, 2026, Daphne Zohar reported holding 1,094,001 shares of Seaport Therapeutics (SPTX). At the last close of $20 on Nov 13, 2026, that is about $21.9M. This is the stake disclosed in filings, not a net worth.
As of the latest filing on , Daphne Zohar reported holding 1,094,001 shares of Seaport Therapeutics (SPTX), worth about $21.9M at the last close of $20 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Seaport Therapeutics SPTX | 1,094,001 | 1.09M direct | $20 | $21.9M | Nov 10, 2026 |
Is this Daphne Zohar’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.